⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Official Title: Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Study ID: NCT03505944

Interventions

Venetoclax

Study Description

Brief Summary: Phase I/II trial, with the aim of evaluating the efficacy of venetoclax to the backbone of rituximab-lenalidomide in patients with relapsed/refractory MCL.

Detailed Description:

Keywords

Eligibility

Minimum Age: 19 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Department of Hematology Aalborg University Hospital, Aalborg, , Denmark

Department of Hematology Aarhus University Hospital, Aarhus, , Denmark

Clinic of Hematology L-4241 Rigshospitalet, Copenhagen, , Denmark

Department of Hematology X Odense University Hospital, Odense, , Denmark

Hæmatologisk Afdeling Zeeland University Hospital, Roskilde, Roskilde, , Denmark

Department of Hematology Helsinki University Hospital Comprehensive Cancer Center, Helsinki, , Finland

Oulu University Hospital, Oulu, , Finland

Tampere University Hospital, Tampere, , Finland

Oslo University Hospital, Oslo, , Norway

Stavanger University Hospital, Stavanger, , Norway

St. Olav Hospital, Trondheim, , Norway

Department of Hematology Linköping University Hospital, Linköping, , Sweden

Department of Medicine Sunderbyn Hospital, Luleå, , Sweden

Skane University Hospital, Lund, , Sweden

Karolinska University Hospital, Stockholm, , Sweden

Department of Oncology Norrland University Hospital, Umeå, , Sweden

Uppsla Academic Hospital, Uppsala, , Sweden

Contact Details

Name: Mats Jerkeman

Affiliation: Skane University Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: